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Endobrevin/VAMP-8 is an R-SNARE localized to endosomes, but it is unknown in which
intracellular fusion step it operates. Using subcellular fractionation and quantitative immunogold
electron microscopy, we found that endobrevin/VAMP-8 is present on all membranes known to
communicate with early endosomes, including the plasma membrane, clathrin-coated pits, late
endosomes, and membranes of the trans-Golgi network. Affinity-purified antibodies that block the
ability of endobrevin/VAMP-8 to form SNARE core complexes potently inhibit homotypic fusion
of both early and late endosomes in vitro. Fab fragments were as active as intact immunoglobulin
Gs. Recombinant endobrevin/VAMP-8 inhibited both fusion reactions with similar potency. We
conclude that endobrevin/VAMP-8 operates as an R-SNARE in the homotypic fusion of early and
late endosomes.
INTRODUCTION
Trafficking of intracellular membranes involves the fusion of
vesicles with their respective target membranes. Intracellu-
lar fusion events are mediated by complementary sets of
SNARE proteins that are localized on the membranes des-
tined to fuse (Rothman, 1994). SNAREs constitute a super-
family of proteins that share a common motif (the SNARE
motif of ;60–70 amino acids) (Jahn and Su¨dhof, 1999). The
best characterized SNAREs are those functioning in exocy-
tosis of synaptic vesicles. They include the vesicle protein
synaptobrevin (also referred to as VAMP) and the plasma
membrane proteins syntaxin 1 and SNAP-25. These proteins
assemble spontaneously into a ternary complex that is dis-
assembled by the chaperone ATPase NSF (NEM [N-ethyl-
maleimide]-sensitive factor) in conjunction with cofactors
called SNAPs (soluble NSF attachment proteins) (So¨llner et
al., 1993). According to a current model, the assembly drives
the fusion reaction by forming a tight connection between
the SNAREs in the partner membranes (trans complexes).
After fusion, the SNAREs within the complex are all aligned
in parallel (cis complexes). They then need to be reenergized
for another round of fusion by NSF and ATP-mediated
disassembly (Hanson et al., 1997).
Sequence comparison revealed that all known SNARE
motifs fall into two major subfamilies that contain either a
conserved glutamine (Q-SNAREs) or a conserved arginine
(R-SNAREs) at a central position (Fasshauer et al., 1998b;
Weimbs et al., 1998). In the neuronal SNARE complex, three
Q-SNARE motifs (one contributed by syntaxin and two by
SNAP-25) and one R-SNARE motif (contributed by synap-
tobrevin/VAMP) form an extended helical bundle (Sutton et
al., 1998). The glutamines and the arginine interact to form
an ionic layer in the middle of the helical bundle that is
surrounded by less well conserved hydrophobic layers. A
similar composition of three Q-SNAREs and one R-SNARE
was also found in a corresponding SNARE complex of yeast.
Together, these observations suggest that all SNARE com-
plexes consist of such four-helix bundles (three Q-SNARE
motifs, one R-SNARE motif) with an asymmetric ionic layer
in the middle.
SNARE complexes other than those functioning in exocy-
tosis of neurons and yeast, however, are less well character-
ized. For instance, in yeast the homotypic fusion of vacuole
precursors is probably mediated by the SNAREs Nyv1p,
Vam7p, and Vam3p (Nichols et al., 1997; Ungermann and
Wickner, 1998), and possibly also Vti1p (Go¨tte and von
Mollard, 1998). Similarly, the SNAREs Sed5p, Sec22p, Bet1p,
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and Bos1p are candidates for the fusion of endoplasmic
reticulum (ER)-derived trafficking vesicles with the cis-
Golgi, but some of these proteins may also be involved in
retrograde traffic from the cis-Golgi to the ER (Spang and
Schekman, 1998). In mammalian cells, the Sed5 orthologue
syntaxin 5 has been shown to be required for the fusion of
ER-derived trafficking vesicles (Dascher et al., 1994; Dascher
and Balch, 1996) with the Golgi apparatus as well as for the
reassembly of Golgi stacks after mitosis (Rabouille et al.,
1998).
Recently, many novel SNAREs have been identified,
mostly as a result of the rapid growth of expressed sequence
tag databases (Bock and Scheller, 1997). Most of them appear
to be localized to specific subsets of intracellular mem-
branes, suggesting that they specifically mediate distinct
fusion steps (for review, see Jahn and Su¨dhof, 1999). How-
ever, a precise subcellular localization of a given SNARE is
a prerequisite, but it is by no means sufficient to pinpoint the
fusion step in which it functions. Every trafficking vesicle
derived from a donor compartment carries SNAREs re-
quired for fusion with its target membrane. Because after
fusion the SNAREs need to recycle to the donor compart-
ment, they must be present not only in the donor and target
compartments but also in all intermediates involved in the
recycling pathway and, furthermore, in the membranes in-
volved in its biogenesis. It is essential, therefore, to map a
given SNARE precisely on intracellular recycling pathways
before hypotheses about the fusion step it mediates can be
proposed.
In the present study, we have focused on the role of a
recently discovered R-SNARE, endobrevin/VAMP-8 (Ad-
vani et al., 1998; Wong et al., 1998b). Endobrevin is only
distantly related to the synaptobrevins and appears to be
localized mainly to an early endosomal compartment. We
now report that in addition to early endosomes, endobrevin
is present on late endosomes and the trans-Golgi network
(TGN) as well as on coated pits and the plasma membrane,
suggesting that it recycles by means of two distinct path-
ways. In line with this intracellular distribution, our data
document that endobrevin functions as an R-SNARE in the
homotypic fusion of both early and late endosomes.
MATERIALS AND METHODS
Materials
Rat syntaxin 1A (residues 1–265) in a pET22b vector encoding for a
factor Xa-cleavable C-terminal His6 fusion protein and a thrombin-
cleavable GST-endobrevin (residues 1–74) expression construct
have been described (Fasshauer et al., 1999). The cDNAs for rat
syntaxin 1A and SNAP-25 were kindly provided by R.H. Scheller
(Stanford University of Medicine, Stanford, CA) and T.C. Su¨dhof
(UT Southwestern Medical Centre, Dallas, TX), respectively.
Antibodies
The following antibodies were described previously: synaptophysin
(rabbit antiserum G96) (Jahn et al., 1985); cellubrevin (rabbit anti-
serum R54) (Annaert et al., 1997); endobrevin (rabbit antiserum)
(Fasshauer et al., 1999); rab5 (mAb Cl 621.3) (Fischer von Mollard et
al., 1994); and rab5 (rabbit antiserum R6) (Fischer von Mollard et al.,
1994). The following antibodies were kind gifts: syntaxin (mAb
HPC-1; provided by Dr. C. Barnstable, Yale School of Medicine,
New Haven, CT) (Barnstable et al., 1985); Sec61a (rabbit serum;
provided by Dr. E. Hartmann, University of Go¨ttingen, Go¨ttingen,
Germany) (Go¨rlich et al., 1992); LIMP II (rabbit antiserum and mAb
provided by Y. Tenaka, Kyushu University, Fukuoka, Japan) (Bar-
riocanal et al., 1986); and MPR46 (rabbit serum MSC1; provided by
A. Hille-Rehfeld, University of Go¨ttingen, Go¨ttingen, Germany).
SCAMP (rabbit serum) was obtained from Synaptic Systems (Go¨t-
tingen, Germany).
Preparation of Fab Fragments
Synaptophysin antiserum was affinity purified as described
(Navone et al., 1986). Endobrevin antiserum was affinity purified
with the use of recombinant GST–endobrevin (Fasshauer et al.,
1999) coupled to cyanogen bromide–Sepharose 4B (Pharmacia, Pis-
cataway, NJ).
Affinity-purified antibodies against endobrevin and synaptophy-
sin were digested with the use of papain beads (Sigma Chemical, St.
Louis, MO) for 90 min at 37°C in PBS containing 1 mM EDTA and
10 mM cysteine, pH 7.4. The beads were then pelleted at 14,000 3 g
for 5 min. Antipain and PMSF were added to the supernatant at
final concentrations of 2 mg/ml and 0.5 mM, respectively. Fab frag-
ments were purified by ion exchange chromatography with the use
of a Mono-Q column on a fast-performance liquid chromatography
system (Pharmacia). Fractions were tested by SDS-PAGE/immuno-
blotting for the presence of Fab fragments and undigested immu-
noglobulin (Ig)Gs. The Fab fragment containing fractions were free
of IgGs, IgMs, or digestive products. The purified Fab fragments
exhibited an affinity similar to that of undigested IgGs when tested
by immunoblotting in serial dilutions.
Subfractionation and Immunoisolation of
Endosomes
For separation of early and late endosomes, postnuclear superna-
tants (PNS) were fractionated with the use of isopycnic sucrose
density gradient centrifugation. PNS were adjusted to 42% sucrose
and overlaid with a discontinuous sucrose gradient according to
Aniento et al. (1993). When the separation was performed after the
fusion reaction, the incubation mix was loaded directly on top of a
continuous sucrose gradient (10–40% [wt/vol] dissolved in 3 mM
imidazole, pH 7.4, 0.5 mM EDTA, 1 mg/ml biotinylated insulin
[Sigma; added as quencher]) and centrifuged for 19 h at 40,000 rpm
in a Beckman (Fullerton, CA) SW 41 rotor.
For immunoisolation, mAb Cl 621.3 (anti-Rab5) and affinity-pu-
rified polyclonal anti-endobrevin antibodies were covalently cou-
pled to Eupergit C1Z methacrylate microbeads as described (Burger
et al., 1989). Liver was homogenized in homogenization buffer (320
mM sucrose, 5 mM HEPES, pH 7.4, 1 mM EDTA, 0.1 mM GTPgS,
and the following protease inhibitors: 10 mg/ml soybean trypsin
inhibitor, 1 mg/ml pepstatin, 11 mg/ml benzamidine, 1 mg/ml
antipain, 1 mg/ml leupeptin, 0.1 mM PMSF) with the use of a
glass–Teflon homogenizer (five strokes, 600 rpm). PNS was gener-
ated by centrifugation at 1000 3 g for 10 min. PNS (200 mg of
protein) was incubated in 400 ml of homogenization buffer with 20
ml of the appropriate beads for 1 h at 4°C. The incubation mixture
was layered on top of a sucrose cushion (0.5 ml, 0.8 M) and centri-
fuged for 5 min at 4600 3 g. The supernatants were centrifuged for
30 min at 200,000 3 g at 4°C with the use of a Beckman TLA120.2
rotor to sediment nonbound membranes. The bead pellets were
washed five times with PBS. Aliquots of each sample as well as the
starting PNS were analyzed by SDS-PAGE and immunoblotting.
For detection of Rab5, a rabbit serum (R6) was used with protein A
coupled to HRP (Sigma) as a secondary antibody to exclude inter-
ference by bead-derived antibodies.
Cell-free Fusion Assay
For measuring endosome fusion, sets of cells were allowed to inter-
nalize biotinylated HRP and avidin, respectively. Upon mixing of
PNS, endosome fusion yields a tight complex between avidin and
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biotinylated peroxidase, which is quantitated after immunoprecipi-
tation (Gruenberg et al., 1989).
Fluid-phase internalization for labeling of early endosomes of
PC12 cells (Greene and Tischler, 1976) was performed as described
(Holroyd et al., 1999). For late endosomes, the labeling time was
increased to 20 min followed by five washes for 5 min with PBS
supplemented with 1 mM MgCl2, 1 mM CaCl2, and 0.5% BSA and
a 60-min chase in marker-free medium supplemented with 0.2%
BSA.
The assay for in vitro fusion of early endosomes of PC12 cells was
performed as described (Holroyd et al., 1999). The assay for late
endosome fusion was identical except that labeling and chase times
were changed as described above. The reaction mixtures were in-
creased to 200 ml (final volume). Where indicated, both PNS frac-
tions were incubated separately with 6 mg of purified Fab fragments
or with recombinant protein (30 mM final concentration) at 37°C for
10 min before combining donor and acceptor PNS fractions for the
fusion reaction. For preincubation with cytosol, donor and acceptor
PNS were incubated with the appropriate Fab fragments, cytosol,
assay buffer, and an ATP-generating system in a final volume of 100
ml. Recombinant synaptobrevin (residues 1–96) (Fasshauer et al.,
1998a) and endobrevin (residues 1–74) (Fasshauer et al., 1999) were
purified as described. All fusion activities were corrected for the
activities measured in the absence of ATP (usually ,1% of the
ATP-dependent activities).
In Vitro Assembly of SNARE Proteins
One microgram of recombinant endobrevin (residues 1–74)
(Fasshauer et al., 1999) was preincubated with 20 mg of affinity-
purified antibodies specific for endobrevin and synaptophysin or
with 7 mg of the corresponding Fab fragments for 15 min at room
temperature. To each sample, 7.5 mg of purified binary complex
consisting of SNAP-25 and the cytoplasmic region of syntaxin 1
(residues 1–265) (Fasshauer et al., 1999) was added and incubated
for 10 h at 4°C. As an assay for assembly, the formation of a
SDS-resistant complex of endobrevin, syntaxin1, and SNAP-25 was
monitored by SDS-PAGE and immunoblotting with the use of the
antibody HPC-1 specific for syntaxin-1.
Electron Microscopy
Immunoelectron microscopy was performed according to the To-
kuyasu method (Tokuyasu, 1973; Slot and Geuze, 1985). Nature rat
kidney (NRK) cells were incubated for 15 min with BSA coupled to
5-nm gold (BSA-gold) before fixation. The cells were fixed for 2 h on
ice with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M
K-phosphate buffer, pH 7.3, and embedded into 10% gelatin. Small
blocks were immersed in 2.3 M sucrose overnight for cryoprotec-
tion. Ultrathin cryosections were cut from the frozen samples and
collected from the diamond knife with a mixture of methylcellulose
and sucrose (Liou et al., 1996). The sections were labeled with
primary antibodies and detected with protein A–gold purchased
from the laboratory of H. Geuze (Utrecht University, Utrecht, the
Netherlands). Immunolabeled sections were contrasted with uranyl
acetate and embedded into uranyl-methyl cellulose and viewed
with a Philips (Eindhoven, the Netherlands) CM120 electron micro-
scope at 80 kV.
RESULTS
Endobrevin/VAMP-8 Is an Abundant Resident of
Early and Late Endosomes
For the characterization of endobrevin, we generated rabbit
antisera with the use of bacterially expressed protein. These
sera reacted with a single band corresponding to endobrevin
in cell extracts (Fasshauer et al., 1999). For further character-
ization, endobrevin-specific antibodies were affinity-puri-
fied with the use of immobilized endobrevin as affinity
matrix.
We first determined the distribution of endobrevin within
the endocytic pathway from the plasma membrane to lyso-
Figure 1. Ultrastructural analysis of endobrevin localization. NRK cells were incubated for 15 min with BSA-gold (5 nm) before fixation and
immunolabeling of endobrevin with the use of an affinity-purified rabbit serum and 15 nm protein A–gold (see MATERIALS AND
METHODS). PM, plasma membrane; E, endosome of vacuolar type; MVB, multivesicular body. Note the association of endobrevin with
tubulovesicular structures (A, triangle), with endosomal structures of vacuolar type (A, and with endosomes appearing as multivesicular
bodies (B). These endobrevin-positive compartments are also positive for the endocytic tracer. Bar, 100 nm.
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somes. NRK cells were incubated with BSA-gold as an en-
docytic marker for 15 min to label endocytic compartments.
The cells were then fixed and analyzed by immunoelectron
microscopy of cryosections. Endobrevin labeling was detect-
able in tubulovesicular structures, small vesicles (Figure 1A,
arrow), and endosomes of vacuolar type (Figure 1A) in
agreement with Wong et al. (1998b). In addition, endobrevin
was found together with BSA-gold in multivesicular bodies
(Figure 1B).
To obtain a more detailed overview of the distribution of
endobrevin, we performed a quantitative analysis of ultra-
thin frozen sections labeled for endobrevin. For comparison,
the sections were double-labeled for LIMP II, a lysosomal
type-3 membrane protein that is also distributed within
endosomes (Barriocanal et al., 1986). In NRK cells, the bio-
synthetic pathway of LIMP II from the TGN to lysosomes is
believed to involve endosomes bypassing the plasma mem-
brane (Barriocanal et al., 1986; R. Tikkanen and S. Ho¨ning,
unpublished data). Endobrevin was abundantly present on
tubulovesicular structures near the plasma membrane (Fig-
ure 1, Table 1) and on multivesicular bodies and vacuolar
endosomes (Figures 1 and 2, Table 1). On the latter compart-
ments, a significant degree of colocalization with LIMP II
was observed: .70% of the endobrevin-positive structures
were also labeled for LIMP II (Table 1). In contrast, only
small amounts of LIMP II labeling were detectable on endo-
brevin-positive tubulovesicular structures near the plasma
membrane. When sections labeled for the endogenous
MPR46 (Hille-Rehfeld, 1995) and endobrevin were exam-
ined, a significant colocalization of endobrevin with MPR46
in TGN-associated structures was observed (Figure 2B, ar-
rowheads). In addition, endobrevin was detectable at the
plasma membrane, in agreement with Wong et al. (1998b),
and occasionally in clathrin-coated pits (Figure 2C).
Together, these data show that endobrevin is abundantly
present on both early and late endosomes. In addition, the
presence on the plasma membrane and coated pits indicates
that endobrevin may also recycle via the plasma membrane.
Endobrevin does not colocalize with the transferrin receptor
(our unpublished results; see also Advani et al., 1998), indicat-
ing that recycling endosomes are largely devoid of the protein.
To examine the association of endobrevin with early and
late endosomes by means of an independent approach, we
immunoisolated organelles containing endobrevin and ana-
lyzed them for the presence of endosomal markers. For
comparison, we also isolated Rab5-containing organelles.
Rab5 is regarded as one of the most specific markers for
early endosomes (Novick and Zerial, 1997). For immunoiso-
lation, antibodies for endobrevin and Rab5 were immobi-
lized on methacrylate microbeads (Eupergit C1Z). Immuno-
beads were incubated with excess amounts of PNS obtained
from rat liver. Under these conditions, antigen-containing
membranes are only partially depleted, whereas the beads
are saturated. This procedure was previously shown to yield
organelles of exceptional purity with minimal contamina-
tion by other subcellular membranes (Burger et al., 1989;
Fischer von Mollard et al., 1994). After isolation of the beads,
the unbound membranes were collected by high-speed cen-
trifugation and used as reference. As shown in Figure 3, both
Rab5 beads– and endobrevin beads–bound membranes con-
tained their respective antigens. About 50% of the antigen-
containing membranes present in the starting material were
bound. Rab5 beads–bound membranes contained endobre-
vin and endobrevin beads–bound membranes contained
Rab5, confirming the association of endobrevin with early
endosomes. Interestingly, however, membranes bound to
endobrevin beads contained relatively less SCAMP and cel-
lubrevin than membranes bound to Rab5 beads. SCAMP
(Brand and Castle, 1993) and cellubrevin (McMahon et al.,
1993) recycle between early endosomes and the plasma
membrane and are thought to be sorted away from late
endosomal/lysosomal compartments. Possibly, there are
pools of cellubrevin/SCAMP-containing membranes that
contain rab5 but are reduced or devoid of endobrevin, e.g.,
in the exocytotic limb of the recycling pathway that is highly
amplified in liver. In contrast, LIMP II was relatively more
enriched on endobrevin beads than on Rab5 beads, confirm-
ing the association of endobrevin with LIMP II–containing
organelles. Sec61a, a component of the protein translocation
complex of the ER (Go¨rlich and Rapoport, 1993), did not
bind to the beads, demonstrating the specificity of the im-
munoisolation procedure. Furthermore, none of the proteins
bound to beads containing no antibodies (control beads).
Endobrevin/VAMP-8 Functions in Fusion of Both
Early and Late Endosomes
The data described above show that endobrevin is widely
distributed within the endocytic pathway extending from
the plasma membrane to early and late endosomes. In ad-
dition, smaller pools of endobrevin are also present on TGN-
associated membranes, which may reflect either newly syn-








Golgi/TGN 12 0 5
Tubules, vesicles not assigned to TGN or PM 18 14 8
Tubulovesicular structures near PM 26 15 8
PM 8 0 2
MVBs/vacuolar endosomes, ATVs 29 71 72
Unclassified 7 0 5
The cells were fixed and labeled for endobrevin and LIMP II as described in MATERIALS AND METHODS. For quantification, 34 sections
were analyzed, and a total of 2800 gold particles were counted. PM, plasma membrane; MVBs, multivesicular bodies; ATVs, associated
tubules and vesicles.
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thesized protein en route to its destination or a recycling
intermediate of the protein. Thus, endobrevin resides on
membranes of two recycling pathways that overlap in the
endosomal compartment: the first between early endosomes
and the plasma membrane, and the second between early
and late endosomes/lysosomes, possibly involving the
TGN. Each of these pathways involves several distinct fu-
sion and budding steps.
Because the highest concentrations of endobrevin were
found on early and late endosomal compartments, we asked
whether the protein may be involved in fusion of early
and/or late endosomes. These fusion reactions are well
characterized now that convenient in vitro assays are avail-
able. Both fusion reactions require NSF and ATP and thus
are likely to be mediated by SNARE proteins (Robinson et
al., 1997). They are distinguished by their preference for the
partner membrane, by their requirements for specific Rab
proteins (Gorvel et al., 1991; Feng et al., 1995), and probably
also by their dependence on Rab-interacting proteins (Sten-
mark et al., 1995; Horiuchi et al., 1997; Simonsen et al., 1998).
To examine whether endobrevin functions in one of these
fusion reactions, we used affinity-purified antibodies as a
tool for blocking its SNARE function. Because assembly of
cognate SNAREs into core complexes is currently thought to
be the decisive step in driving membrane fusion, we first
investigated whether the antibodies inhibited the ability of
endobrevin to form SDS-resistant complexes. The cognate
SNARE partners of endobrevin are not known at present.
However, recent evidence has shown that endobrevin can
substitute for synaptobrevin in neuronal SNARE complexes.
Figure 2. Immunogold localization of endobrevin and LIMP II. Ultrathin cryosections of NRK cells were immunolabeled for endobrevin
(15-nm protein A–gold) and either LIMP II (10-nm protein A–gold; A) or the endogenous MPR46 (10-nm protein A–gold; B and C).
Endobrevin is detectable in tubulovesicular structures (arrows in A), underneath the plasma membrane (PM), and on endosomal vacuoles
(E) and endosomes that appear as multivesicular bodies (MVB), where it often colocalizes with the lysosomal membrane protein LIMP II. We
also noted a colocalization of endobrevin with MPR46 in TGN-associated structures (B, arrowheads) and occasionally the appearance in
coated pits/vesicles at the plasma membrane (C, arrow). Bars, 100 nm.
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The resulting complex is very similar to the neuronal com-
plex with respect to a-helical content, SDS and heat resis-
tance, stoichiometry, and susceptibility to disassembly by
NSF (Fasshauer et al., 1999; Yang et al., 1999), thus providing
a convenient model for endobrevin–SNARE complexes.
Recombinant endobrevin was incubated with affinity-pu-
rified antibodies for 15 min and then combined with recom-
binant syntaxin 1 and SNAP-25 for the formation of ternary
complexes. As a control, parallel incubations were per-
formed with affinity-purified rabbit antibodies for synapto-
physin, a major integral membrane protein of synaptic ves-
icles (Jahn et al., 1985; Wiedenmann and Franke, 1985). As
shown in Figure 4 (middle lanes), incubation with endobre-
vin antibodies completely prevented the formation of SDS-
resistant complexes. In contrast, complexes were formed
when synaptophysin IgG was used or when the antibodies
were omitted. Virtually identical results were obtained
when Fab fragments instead of intact antibodies were used
in the experiment (Figure 4, right lanes).
Next we investigated whether these Fab fragments had an
effect on the in vitro fusion of early and late endosomes. For
both fusion reactions, in vitro assays are available that were
used here with slight modifications. PC12 cells were pre-
loaded by endocytosis with complementary fluid-phase
markers with the use of a 5-min pulse for the labeling of
early endosomes and a 20-min pulse followed by a 60-min
chase for the labeling of late endosomes. After homogeniza-
tion, PNS were prepared and combined to initiate the in
vitro fusion reaction. Upon fusion, the endocytosed markers
form a complex that could be quantified. In some experi-
ments, early and late endosomes were separated by sucrose
density gradient centrifugation before the fusion assay.
The assays for homotypic fusion of early endosomes and
late endosomes showed high ATP-dependent fusion activity
(Table 2). In contrast, heterotypic fusion of early and late
endosomes was inefficient regardless of whether early or
late endosomes were labeled with biotinylated HRP or avi-
din, respectively. The activities were ;25% of late endosome
Figure 3. Characterization of organelles immu-
noisolated with microbeads containing antibodies
specific for endobrevin and Rab5. A PNS from rat
liver was incubated with small amounts of immuno-
beads containing covalently bound antibodies spe-
cific for Rab5 and endobrevin (eb). Glycine-inacti-
vated beads (con.) served as control for nonspecific
binding. The protein composition of the bead-bound
membranes (bound) was compared with that of un-
bound membranes that were sedimented by ultra-
centrifugation (unbound). Equal proportions of all
fractions were analyzed by immunoblotting. PNS,
postnuclear supernatant used as starting material;
sup, membrane-free supernatant obtained after ul-
tracentrifugation and concentrated by precipitation
according to Wessel and Flu¨gge (1984); cb, cellubre-
vin. PNS, supernatant, and unbound fractions, 10 mg
of protein/lane; bead-bound material, ;6 ml of
beads. Note that the membrane protein content of
the beads is at least 5- to 10-fold lower than of the
unbound fraction. Also, note that to saturate the
beads with organelles, an excess of PNS was used,
explaining why none of the antigens was depleted.
Figure 4. Antibodies specific for endobrevin prevent formation of
SDS-resistant SNARE complexes with SNAP-25 and syntaxin 1A.
Endobrevin was preincubated with affinity-purified antibodies
(IgG) or Fab fragments specific for endobrevin (eb) or synaptophy-
sin (syp) followed by the addition of preassembled SNAP-25/syn-
taxin 1 complexes. Formation of SDS-resistant complexes was mon-
itored by immunoblotting with the use of an antibody specific for
syntaxin 1. SDS-resistant core complexes are dissociated by boiling
(left lane; cf. Hayashi et al., 1994).
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fusion activity and 15% of early endosome fusion activity
(Table 2). These data show that early endosome and late
endosome fusion are distinct fusion events with only minor
cross-contamination, in agreement with earlier results
(Aniento et al., 1993). For further confirmation, we analyzed
the fused membrane vesicles by sucrose density gradient
centrifugation. As shown in Figure 5, the fusion products of
early and late endosome fusion were well separated. Fur-
thermore, the fusion products of late endosome fusion comi-
grated with MPR300 but were devoid of cellubrevin, trans-
ferrin receptor, and synaptobrevin (our unpublished
results), demonstrating that they are free of early endosomes
and synaptic vesicles.
When endobrevin-specific antibodies (Fab fragments)
were added 10 min before initiation of the reaction, a sig-
nificant inhibition of fusion was observed: early endosome
fusion was inhibited by ;50%, and late endosome fusion
was inhibited by ;60% (Figure 6). Very similar results (early
endosomes, 52% inhibition; late endosomes, 65% inhibition;
data from a single experiment) were obtained when early
and late endosomes were prepurified by sucrose gradient
centrifugation. As a control, we used antibodies (Fab frag-
ments) specific for synaptophysin, an abundant membrane
protein of recycling organelles of neuroendocrine cells, in-
cluding PC12 cells. These antibodies had no effect on the
fusion of late endosomes and only a minor inhibitory effect
on early endosome fusion (Figure 6) (see DISCUSSION).
Preincubation of anti-endobrevin Fab fragments with stoi-
chiometric amounts of recombinant endobrevin restored fu-
sion activity (our unpublished results), confirming that in-
hibition of fusion by anti-endobrevin antibodies is due to
specific interference with this protein.
It should be noted that inhibition of fusion was not com-
plete. It is possible that antibody binding to endobrevin is
inefficient because the protein is complexed to other
SNAREs most of the time, forming cis complexes in the
endosomal membrane. Because no ATP is present during
the preincubation, such complexes would not be disassem-
bled by NSF, resulting in protection of endobrevin from the
inactivating antibody until the fusion reaction is initiated.
Therefore, Fab fragment preincubation was carried out in
the presence of ATP and cytosol as a source for NSF and
SNAPs. However, the degree of inhibition did not increase
significantly under these conditions, even when the concen-
trations of NSF and a-SNAP were increased by the addition
of purified proteins (our unpublished results; see DISCUS-
SION).
Table 2. ATP-dependent fusion activities (HRP relative units) for
early (EE) and late (LE) endosome preparations, labeled with either
biotinylated HRP or avidin
EE HRP LE HRP
EE avidin 322 41
LE avidin 47 181
The data are from a representative experiment. Early endosomes
were labeled by 5 min of incubation, and late endosomes were
labeled by 20 min of incubation followed by a 60-min chase period
(see MATERIALS AND METHODS for details).
Figure 5. Separation of early
and late endosomes by continu-
ous sucrose density gradient cen-
trifugation after completion of
the homotypic fusion reaction.
Fusion reactions were carried out
for early (circles) and late (trian-
gles) endosomes in the presence
(closed symbols) or absence
(open symbols) of ATP and then
loaded in parallel on top of 10–
40% continuous sucrose gradi-
ents (see MATERIALS AND
METHODS). At the end of the
run, fractions of 0.5 ml were col-
lected manually and analyzed by
immunoprecipitation for the
presence of fusion product. Each
immunoprecipitate was assayed
for HRP activity with the use of a
photometric assay (bottom). The
top panel shows the sucrose con-
centration of each gradient as de-
termined by refractometry (data
were obtained from a single ex-
periment).
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To confirm the role of endobrevin in early and late endo-
some fusion by an independent approach, we examined
whether the addition of recombinant endobrevin inhibits
fusion. As discussed above, the R-SNARE endobrevin is
thought to form a complex with cognate SNARE partners
during the fusion reaction. Excess amounts of the cytosolic
part of endobrevin, therefore, are expected to compete with
the endogenous protein. As shown in Figure 6 (right panels),
recombinant endobrevin inhibited both fusion reactions as
effectively as the Fab fragments. As a control, we added
identical amounts of recombinant synaptobrevin, an
R-SNARE functioning in exocytosis that is abundantly
present on PC12 cell endosomes. No inhibition of either
fusion reaction was observed. We conclude from these ex-
periments that endobrevin functions as an R-SNARE in the
fusion of two distinct intracellular fusion reactions.
DISCUSSION
In the present study, we have shown that endobrevin, an
R-SNARE with a widespread distribution throughout the
endocytic pathway, functions in the homotypic fusion of
early and late endosomes.
Two independent approaches were chosen to investigate
the role of endobrevin in endosome fusion, giving similar
results. Antibodies are frequently used to inhibit the func-
tion of a protein in membrane fusion (McBride et al., 1999).
However, it needs to be borne in mind that inhibition of
fusion may be caused by the presence of bulky IgG mole-
cules on the fusing membranes, thereby preventing mem-
brane contact. An appropriate control for such indirect in-
hibition involves the use of antibodies specific for an
abundant membrane protein of endosomes that is not in-
volved in membrane fusion. Therefore, we chose PC12 cells,
which, unlike neurons, abundantly express endobrevin, al-
lowing us to use probes specific for synaptic vesicle proteins
such as synaptophysin. Synaptophysin is highly abundant
not only on exocytotic vesicles but also on early endosomes
(Holroyd et al., 1999), providing a convenient control, at least
for the fusion of early endosomes. Interestingly, intact IgG
specific for synaptophysin (in contrast to Fab fragments)
potently inhibited this fusion step (our unpublished obser-
vations), confirming that inhibition of in vitro fusion reac-
tions may indeed be caused by such indirect effects.
It is noteworthy that the fusion reactions are inhibited by
the addition of exogenous soluble endobrevin but not of
synaptobrevin. In vitro, both endobrevin and synaptobrevin
form SNARE complexes of similar structural properties with
the same partner proteins (Fasshauer et al., 1999; Yang et al.,
1999). The selectivity observed here supports the view that
there must be at least some preference for the cognate
SNARE. Preliminary observations suggest that this specific-
ity may be overcome by the use of excessive amounts of
synaptobrevin (our unpublished observations).
It remains to be established whether endobrevin is the
only R-SNARE required for early and late endosome fusion
or whether other, hitherto unidentified, R-SNAREs operate
alongside endobrevin. The latter possibility is suggested by
the observation that some fusion persisted in the presence of
our antibodies, although these antibodies completely pre-
vented assembly of endobrevin with Q-SNAREs in an in
vitro assembly assay. Interestingly, neurons do not express
endobrevin (Advani et al., 1998; our unpublished observa-
tions), although fusion of early endosomes is thought to be
involved in both synaptic and extrasynaptic trafficking path-
ways (Jessell and Kandel, 1993), suggesting the involvement
of additional R-SNAREs. Cellubrevin, an abundant
R-SNARE recycling between the plasma membrane and
early endosomes, is not involved in early endosome fusion.
Unlike endobrevin (our unpublished observations), cel-
lubrevin is efficiently cleaved by clostridial neurotoxins,
whereas endosome fusion is not affected by toxin treatment
(Link et al., 1993; Holroyd et al. 1999). Rather, cellubrevin
appears to function in the fusion of transport vesicles with
the plasma membrane (Galli et al., 1994). Recently, VAMP-7,
which is localized to late endosomes in addition to the TGN
Figure 6. Fusion of early and late endosomes is inhibited by Fab
fragments specific for endobrevin or by recombinant endobrevin.
Fusion of early and late endosomes derived from PC12 cells was
monitored in vitro with the use of a content-mixing assay (see
MATERIALS AND METHODS). For preincubation of PNS, 1.2 mM
Fab fragments specific for endobrevin (eb) or synaptophysin (syp)
(left panels) or 30 mM soluble recombinant endobrevin or synapto-
brevin (sb) (right panels) was used. ATP-dependent fusion activity
in the absence of Fab fragments or recombinant protein is defined as
100%. Values are given as means of four independent experiments,
and bars indicate the range. Fusion was initiated by mixing donor
and acceptor fractions while simultaneously adding ATP and cy-
tosol, followed by 30 min of incubation.
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and transport vesicles, has been suggested to operate in
membrane traffic from the late endosome to the lysosome
(Advani et al., 1999). Other candidates include VAMP-4,
which was localized to endosomes (Steegmaier et al., 1999).
It is not yet known with which Q-SNAREs endobrevin
interacts and whether its Q-SNARE partners are identical in
the two fusion reactions. Recently, syntaxin 7 (Wong et al.,
1998a) and syntaxin 12/13 (Advani et al., 1998; Tang et al.,
1998) (syntaxin 12 and syntaxin 13 probably represent in-
complete sequences of the same protein) have been localized
to early endosomes, making them candidates for such Q-
SNARE partners. Furthermore, syntaxin 13 was recently
suggested to be involved in the fusion of early endosomes
(McBride et al., 1999). In preliminary experiments, however,
we were unable to coprecipitate endobrevin with syntaxin
13 from tissue extracts (our unpublished observations). Also,
it remains to be established whether a relative of SNAP-25,
e.g., SNAP-23 (Ravichandran et al., 1996) or the recently
identified SNAP-29/GS-32 (Steegmaier et al., 1998; Wong et
al., 1999), is participating in endobrevin–SNARE complexes.
In conclusion, our data lend strong support to the view
that the assembly of specific sets of SNARE proteins is
involved in many, perhaps all, intracellular fusion steps. The
ongoing characterization of new mammalian SNAREs raises
the hope that the SNARE partners of endobrevin as well as
the SNARE complexes functioning in other intracellular fu-
sion steps will soon be identified.
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